The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B ...

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.

As RFK Jr.'s new vaccine panel ponders changing the hepatitis B vaccination schedule, some doctors recall past patients, ...

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

The three-dose hepatitis B vaccine has a long track record of safety, but rolling back recommendations could leave kids ...

Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the ...

Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead ...

My father didn’t know it, but by the time his urine had turned dark, the color of tea, he had only a month or so to live.

GlobalData expects the chronic hepatitis B therapeutics market across major markets to climb from $1.5 billion in 2024 to ...

Hundreds of people have been diagnosed with either HIV or hepatitis B since A&E departments across the Midlands started ...